Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yutaro Miura

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Journal of Medicinal Chemistry|December 15, 2025
Antibody-Drug Conjugates Using CD4 Mimics and a Neutralizing Antibody as HIV-1 Entry InhibitorsYutaro Miura, Kohei Tsuji, Takuya Kobayakawa, et al.
Chemmedchem|February 12, 2026
CD4 Mimic-Neutralizing Antibody Conjugates Synthesized by Site-Specific Modification Methods as HIV-1 Entry InhibitorsKohei Tsuji, Yutaro Miura, Takeo Kuwata, et al.
RSC Medicinal Chemistry|October 20, 2023
Development of anti-HBV agents targeting HBV capsid proteinsTakuya Kobayakawa, Masayuki Amano, Miyuki Nakayama, et al.
ACS Omega|September 22, 2025
SARS-CoV‑2 Main Protease Inhibitors Containing 5‑Substituted Benzothiazole-2-carbonyl Moieties at the P1' Site and Their DerivativesKohei Tsuji, Takuya Kobayakawa, Nobuyo Higashi-Kuwata, et al.
RSC Advances|March 23, 2023
Dimerized fusion inhibitor peptides targeting the HR1-HR2 interaction of SARS-CoV-2Kohei Tsuji, Kofi Baffour-Awuah Owusu, Yutaro Miura, et al.
Journal of Medicinal Chemistry|September 27, 2023
Structure-Activity Relationship Studies of SARS-CoV-2 Main Protease Inhibitors Containing 4-Fluorobenzothiazole-2-carbonyl MoietiesKohei Tsuji, Takahiro Ishii, Takuya Kobayakawa, et al.
Chemical & Pharmaceutical Bulletin|December 3, 2023
Exploratory Studies of Effective Inhibitors against the SARS-CoV-2 Main Protease by Halogen Incorporation and Amide Bond ReplacementKohei Tsuji, Takuya Kobayakawa, Takahiro Ishii, et al.
RSC Advances|January 30, 2023
Low-molecular-weight anti-HIV-1 agents targeting HIV-1 capsid proteinsTakuya Kobayakawa, Masaru Yokoyama, Kohei Tsuji, et al.
Chemical & Pharmaceutical Bulletin|January 3, 2024
Development of Small-Molecule Anti-HIV-1 Agents Targeting HIV-1 Capsid ProteinsTakuya Kobayakawa, Masaru Yokoyama, Kohei Tsuji, et al.
Plos Pathogens|December 17, 2025
Netrin-1 inhibits the attachment and internalization of Hepatitis B virus for hepatocyte infectionYing Wang, Kazuhisa Murai, Atsuya Ishida, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Journal of Medicinal Chemistry|December 15, 2025
Antibody-Drug Conjugates Using CD4 Mimics and a Neutralizing Antibody as HIV-1 Entry InhibitorsYutaro Miura, Kohei Tsuji, Takuya Kobayakawa, et al.
Chemmedchem|February 12, 2026
CD4 Mimic-Neutralizing Antibody Conjugates Synthesized by Site-Specific Modification Methods as HIV-1 Entry InhibitorsKohei Tsuji, Yutaro Miura, Takeo Kuwata, et al.
RSC Medicinal Chemistry|October 20, 2023
Development of anti-HBV agents targeting HBV capsid proteinsTakuya Kobayakawa, Masayuki Amano, Miyuki Nakayama, et al.
ACS Omega|September 22, 2025
SARS-CoV‑2 Main Protease Inhibitors Containing 5‑Substituted Benzothiazole-2-carbonyl Moieties at the P1' Site and Their DerivativesKohei Tsuji, Takuya Kobayakawa, Nobuyo Higashi-Kuwata, et al.
RSC Advances|March 23, 2023
Dimerized fusion inhibitor peptides targeting the HR1-HR2 interaction of SARS-CoV-2Kohei Tsuji, Kofi Baffour-Awuah Owusu, Yutaro Miura, et al.
Journal of Medicinal Chemistry|September 27, 2023
Structure-Activity Relationship Studies of SARS-CoV-2 Main Protease Inhibitors Containing 4-Fluorobenzothiazole-2-carbonyl MoietiesKohei Tsuji, Takahiro Ishii, Takuya Kobayakawa, et al.
Chemical & Pharmaceutical Bulletin|December 3, 2023
Exploratory Studies of Effective Inhibitors against the SARS-CoV-2 Main Protease by Halogen Incorporation and Amide Bond ReplacementKohei Tsuji, Takuya Kobayakawa, Takahiro Ishii, et al.
RSC Advances|January 30, 2023
Low-molecular-weight anti-HIV-1 agents targeting HIV-1 capsid proteinsTakuya Kobayakawa, Masaru Yokoyama, Kohei Tsuji, et al.
Chemical & Pharmaceutical Bulletin|January 3, 2024
Development of Small-Molecule Anti-HIV-1 Agents Targeting HIV-1 Capsid ProteinsTakuya Kobayakawa, Masaru Yokoyama, Kohei Tsuji, et al.
Plos Pathogens|December 17, 2025
Netrin-1 inhibits the attachment and internalization of Hepatitis B virus for hepatocyte infectionYing Wang, Kazuhisa Murai, Atsuya Ishida, et al.
Pageof 2